Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
The study analyzed 2,541 patients hospitalized among the system’s six hospitals between March 10 and May 2 and found 13% of those treated with hydroxychloroquine died while 26% of those who did not receive the drug died.
Hasn't gotten wide media attention. I wonder why...
The study analyzed 2,541 patients hospitalized among the system’s six hospitals between March 10 and May 2 and found 13% of those treated with hydroxychloroquine died while 26% of those who did not receive the drug died.
So to put it simply...
13 patients out of 100 treated with hydroxychloroquine passed away
26 of those 100 who were not treated with the drug passed away
"13% of those treated with hydroxychloroquine died"
Remdesivir's mortality rate is 7.1%, so it's nearly twice as effective.
Maybe that's why the study isn't getting much attention, it doesn't work that well.
The study analyzed 2,541 patients hospitalized among the system’s six hospitals between March 10 and May 2 and found 13% of those treated with hydroxychloroquine died while 26% of those who did not receive the drug died.
The study analyzed 2,541 patients hospitalized among the system’s six hospitals between March 10 and May 2 and found 13% of those treated with hydroxychloroquine died while 26% of those who did not receive the drug died.
So to put it simply...
13 patients out of 100 treated with hydroxychloroquine passed away
26 of those 100 who were not treated with the drug passed away
Otherwise the drug is killing 13 more people per 100 than if someone just went cold turkey. Ok
"13% of those treated with hydroxychloroquine died"
Remdesivir's mortality rate is 7.1%, so it's nearly twice as effective.
Maybe that's why the study isn't getting much attention, it doesn't work that well.
Quote:
Trial results also suggested a survival benefit, with a 14-day mortality rate of 7.1% for the group receiving remdesivir versus 11.9% for the placebo group; however, the difference in mortality was not statistically significant.
Looks like they were using it on people who weren't as sick.
Please register to post and access all features of our very popular forum. It is free and quick. Over $68,000 in prizes has already been given out to active posters on our forum. Additional giveaways are planned.
Detailed information about all U.S. cities, counties, and zip codes on our site: City-data.com.
Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
